Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin plus Cisplatin and Gemcitabine in Advanced Non-Squamous NSCLC
NCT00806923Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2005
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 20
01
Overview
A Phase 3 trial of bevacizumab in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Roche. Started Feb 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT00806923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00806923.